Related references
Note: Only part of the references are listed.The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
Xin Hu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen Signaling Pathway
Yusheng Guo et al.
FRONTIERS IN ONCOLOGY (2022)
The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy
Qi Wang et al.
BMC GASTROENTEROLOGY (2022)
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2022)
A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection
Wencui Li et al.
DIAGNOSTICS (2022)
Combinatory local ablation and immunotherapies for hepatocellular carcinoma: Rationale, efficacy, and perspective
Shuling Chen et al.
FRONTIERS IN IMMUNOLOGY (2022)
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
Philip Johnson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
Deep-learning-based analysis of preoperative MRI predicts microvascular invasion and outcome in hepatocellular carcinoma
Bao-Ye Sun et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)
Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy
Wenying Qiao et al.
FRONTIERS IN IMMUNOLOGY (2022)
The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma
BoZhi Liu et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2022)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The Significance of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in the Early Postoperative Recurrence Monitoring and Prognosis Prediction of AFP-Negative Hepatocellular Carcinoma
Siming Li et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma After Locoregional Therapy: A 5-Year Prospective Cohort Study
Qi Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma
Shuqi Mao et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC
Xiu-Mei Bai et al.
RADIOLOGY (2021)
Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series
Rukaiya Bashir Hamidu et al.
VACCINES (2021)
Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection
Jian Huang et al.
CANCER MEDICINE (2020)
New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
Ting Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Peter R. Galle et al.
LIVER INTERNATIONAL (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Combination of the gamma-glutamyltransferase-to-prealbumin ratio and other indicators may be a novel marker for predicting the prognosis of patients with hepatocellular carcinoma undergoing locoregional ablative therapies
Q. Wang et al.
INFECTIOUS AGENTS AND CANCER (2019)
A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies
Qi Wang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma
Xueping Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
Yutaka Kurebayashi et al.
HEPATOLOGY (2018)
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
Jean-Charles Nault et al.
JOURNAL OF HEPATOLOGY (2018)
New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection
Wei Gan et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
The immunology of hepatocellular carcinoma
Marc Ringelhan et al.
NATURE IMMUNOLOGY (2018)
Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection
Shu-Yein Ho et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Microvascular invasion of single small hepatocellular carcinoma ≤3 cm: Predictors and optimal treatments
Yo-ichi Yamashita et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2018)
Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions
Won Young Tak et al.
CLINICAL CANCER RESEARCH (2018)
Ductular reaction, cytokeratin 7 positivity, and gamma-glutamyl transferase in multistage hepatocarcinogenesis in rats
Andrea Janz Moreira et al.
PROTOPLASMA (2017)
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2017)
The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma
Dou-Sheng Bai et al.
SCIENTIFIC REPORTS (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression
Zhen-zhen Chen et al.
NATURE COMMUNICATIONS (2016)
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong-Won Park et al.
LIVER INTERNATIONAL (2015)
Image-guided ablation of primary liver and renal tumours
David J. Breen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: A prospective randomized controlled trial
Kaiyun Chen et al.
JOURNAL OF HEPATOLOGY (2014)
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis
Edoardo G. Giannini et al.
HEPATOLOGY (2012)
Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion
Junping Ao et al.
MOLECULAR ONCOLOGY (2012)
The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011
Peipei Song et al.
LIVER INTERNATIONAL (2012)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma
TM Pawlik et al.
LIVER TRANSPLANTATION (2005)
Mechanisms of focal heat destruction of liver tumors
M Nikfarjam et al.
JOURNAL OF SURGICAL RESEARCH (2005)
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA):: a prospective study
C Cammà et al.
JOURNAL OF HEPATOLOGY (2005)
Share Paper
